Parameters values for the baseline scenario correspond to the posterior median value <i>β</i>_<i>base</i> = 0.31, <i>ω</i>_<i>base</i> = 0.12, λ<sub><i>v</i>1</... by Maria L. Daza–Torres (12568896)

Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

“…Right plot show the gradual decrease in the TM tuning for the features highlighted in <b>c</b> as well as the gradual increase in the temporal response profile (i.e. optimal shifts for the prediction of the key BO-NN features using Praat features shown in <b>a</b>). …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

Data and statistical information for Figs 3–6. by Lindsay E. Martin (17377067)

Stimulation with PMA in Jurkat cells led to a decrease in promoter activity. by Maike Stegen (8578665)

Prevalence of hyperemic coronary flow decrease. by Eisuke Usui (12111855)

Prediction of hyperemic coronary flow decrease. by Eisuke Usui (12111855)

Fig 6 - by Koffi Djaman (3374105)

Subjects:

Odds ratios for IVW MR estimates for each outcome with <i>cis</i>CRP exposures and are on the scale of lnCRP decrease. by Fergus W. Hamilton (10724401)

Subjects:

Alpha diversity in F2 samples with sulfite treatment at time 0. by Sally V. Irwin (4521733)

Maximum body temperature decrease within eight hours after administration of dipyrone, acetaminophen or no medication. by Hans-Jörg Gillmann (8460585)

Subjects:

SLAMF6 knock down or knock out leads to a decrease in TCR activation. by Matthew A. Dragovich (6843362)

Inhibition of Wnt signaling pathway or absence of TSP1 decreases cellular <i>T</i>. <i>cruzi</i> infection. by Ashutosh Arun (2574559)

Repeated LSPC treatment prolongs survival of and decreases PrP^Res accumulation in a subset of prion-infected mice. by Heather Bender (363996)

Table 6_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

“…</p>Results<p>After transportation, intestinal motility grades were reduced [Tpre median (IQR) composite motility grade: 8 (7-10), T1: 6 (4-7), T2: 7 (6-7); p < 0.001] and qualitative changes were observed in small intestinal sonographic appearance. …”

Ce6 decreases the amount of TMV PQS5 upon photo-irradiation. by Congbao Xie (17599247)

Suppression of STAT6 consistently decreases WT_III encystment. by Joshua A. Kochanowsky (7543169)